» Articles » PMID: 9690675

Progressive Neuronal Injury Associated with Amyloid Plaque Formation in Alzheimer Disease

Overview
Specialties Neurology
Pathology
Date 1998 Aug 5
PMID 9690675
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Neuronal injury associated with amyloid plaque progression in Alzheimer disease was examined using TUNEL combined with beta-amyloid immunolabeling. There was a progressive increase in the frequency of TUNEL-positive neurons associated with plaque types representing a hypothesized sequence of plaque evolution, from 20% of neurons not associated with plaques to 40%, 70-80%, and 100% of neurons in diffuse, neuritic, and dense-core non-neuritic plaques, respectively. The total number of neurons associated with end-stage, dense-core, non-neuritic plaques declined by 70% (per unit plaque area) compared with neuritic plaque forms. This decline, together with the fact that virtually all of those remaining were TUNEL-positive, suggests that neuronal cell damage increases as plaques evolve from diffuse to more complex forms and that eventually all plaque-associated neurons are lost. This novel demonstration of neurotoxicity associated with amyloid plaque formation and progression suggests that plaque-associated neuronal injury is a major cause of neuronal loss in Alzheimer disease.

Citing Articles

Unsaturated Fatty Acids Are Decreased in Aβ Plaques in Alzheimer's Disease.

Rohr D, Helfrich M, Horing M, Grosseruschkamp F, Liebisch G, Gerwert K J Neurochem. 2025; 169(1):e16306.

PMID: 39825731 PMC: 11742699. DOI: 10.1111/jnc.16306.


New Views of the DNA Repair Protein Ataxia-Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases.

Briguglio S, Cambria C, Albizzati E, Marcello E, Provenzano G, Frasca A Cells. 2023; 12(17).

PMID: 37681912 PMC: 10486624. DOI: 10.3390/cells12172181.


Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer's disease?.

Sbai O, Bazzani V, Tapaswi S, McHale J, Vascotto C, Perrone L Front Mol Neurosci. 2023; 16:1166879.

PMID: 37251647 PMC: 10213291. DOI: 10.3389/fnmol.2023.1166879.


Reduction in GABAB on glia induce Alzheimer's disease related changes.

Leisgang Osse A, Pandey R, Wirt R, Ortiz A, Salazar A, Kimmich M Brain Behav Immun. 2023; 110:260-275.

PMID: 36906075 PMC: 10115139. DOI: 10.1016/j.bbi.2023.03.002.


Long RNA Profiles of Human Brain Extracellular Vesicles Provide New Insights into the Pathogenesis of Alzheimer's Disease.

Luo D, Liu H, Liu H, Wu W, Zhu H, Ge W Aging Dis. 2023; 14(1):229-244.

PMID: 36818567 PMC: 9937700. DOI: 10.14336/AD.2022.0607.


References
1.
Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K . Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 1995; 89(1):35-41. DOI: 10.1007/BF00294257. View

2.
Griffin W, Sheng J, Roberts G, Mrak R . Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol. 1995; 54(2):276-81. DOI: 10.1097/00005072-199503000-00014. View

3.
Anderson A, Su J, Cotman C . DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci. 1996; 16(5):1710-9. PMC: 6578676. View

4.
Troncoso J, Sukhov R, Kawas C, Koliatsos V . In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J Neuropathol Exp Neurol. 1996; 55(11):1134-42. DOI: 10.1097/00005072-199611000-00004. View

5.
Griffin W, Sheng J, Royston M, Gentleman S, McKenzie J, Graham D . Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 1998; 8(1):65-72. PMC: 8098321. DOI: 10.1111/j.1750-3639.1998.tb00136.x. View